The use of nucleic acid analogues in diagnostics and analytical procedures
CA 2109805 A1 · Owner: Buchardt, Ole · Inventors: Buchardt, Ole; Nielsen, Peter E.; Egholm, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of capture, recognition detection, identification or quantitation of nucleic acids and diagnostics uses generally are described in which are used (a) a peptide nucleic acid (PNA) comprising a polyamide backbone bearing a plurality of ligands at respective spaced locations along said backbone, said ligands being each independently naturally occurring nucleobases non-naturally, occurring nucleobases or nucleobase-binding groups each said, ligand being bound directly or indirectly to a nitrogen atom in said backbone, and said ligand bearing nitrogen atoms mainly being separated from one another in said backbone by from 4 to 8 intervening atoms;, (b) a nucleic acid analogue capable of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 22, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 22, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 22, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.